Caregen is a global leader in peptide R&D, headquartered in South Korea. Since 2001, Caregen has developed and
commercialized over 1,500 functional peptides, driving innovation across cosmeceuticals, Class III medical devices,
nutraceuticals, and pharmaceuticals.
The company’s mission is to enhance life and health through the development, production, and global distribution of
advanced functional peptides. Its products support wellness, metabolic balance, and healthy aging for people
worldwide.
Caregen’s research goes beyond biomimetic peptides. It uses proprietary peptide engineering to improve efficacy,
safety, and delivery, enabling new possibilities in pharmaceutical applications.
We export to over 130 countries and hold the world’s largest peptide patent portfolio under a single entity,
covering core sequences, indications, and formulations. This IP strength enables strategic global licensing and co
development partnerships.
By integrating pharmaceuticals, functional foods, and medical devices, Caregen continues to lead peptide innovation
with a focus on safety, science, and scalability
| Primary business activity | Manufacturer: Ingredients / Additives |
|---|---|
| Affiliated categories: | Collagen peptides |Other Amino acids |Other Bioactives More |